Risk‐adapted stereotactic body radiation therapy for central and ultra‐central early‐stage inoperable non‐small cell lung cancer

To determine the therapeutic efficacy and safety of risk‐adapted stereotactic body radiation therapy (SBRT) schedules for patients with early‐stage central and ultra‐central inoperable non‐small cell lung cancer. From 2006 to 2015, 80 inoperable T1‐2N0M0 NSCLC patients were treated with two median d...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Sci
Hlavní autoři: Meng, Mao‐Bin, Wang, Huan‐Huan, Zaorsky, Nicholas G., Sun, Bing‐Shen, Zhu, Lei, Song, Yong‐Chun, Li, Feng‐Tong, Dong, Yang, Wang, Jing‐Sheng, Chen, Hua‐Ming, Yu, Xu‐Yao, Yuan, Zhi‐Yong
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2019
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6825012/
https://ncbi.nlm.nih.gov/pubmed/31464032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14185
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky